Length of postoperative hospital stay · patients undergoing surgery for head and neck cancer
Immunonutrition showed no clear difference in postoperative length of hospital stay (days) compared with standard care (low certainty).
1 finding from 1 review
Wound infection · patients undergoing surgery for head and neck cancer
It is very uncertain whether immunonutrition changes wound infection compared with standard care (very low certainty).
1 finding from 1 review
Fistula formation · patients undergoing surgery for head and neck cancer
Immunonutrition may leads to lower fistula formation compared with standard care (low certainty).
1 finding from 1 review
Adverse events/tolerance of feeds · patients undergoing surgery for head and neck cancer
It is very uncertain whether immunonutrition changes adverse events/tolerance of feeds compared with standard care (very low certainty).
1 finding from 1 review
All‐cause mortality · patients undergoing surgery for head and neck cancer
Immunonutrition showed no clear difference in all‐cause mortality compared with standard care (low certainty).
1 finding from 1 review
Complications
Immunonutrition showed no clear difference in complications compared with standard nutritional supplements (low certainty).
1 finding from 1 review
Length of hospital stay
1 finding from 1 review
All‐cause mortality
Immunonutrition may leads to lower mortality compared with standard nutritional supplements (low certainty).
1 finding from 1 review
All‐cause mortality · patients with acute pancreatitis
Immunonutrition may leads to lower all‐cause mortality compared with control (low certainty).
1 finding from 1 review
Systemic inflammatory response syndrome · patients with acute pancreatitis
Immunonutrition showed no clear difference in systemic inflammatory response syndrome compared with control (low certainty).
1 finding from 1 review
Organ failure · patients with acute pancreatitis
Immunonutrition showed no clear difference in organ failure compared with control (low certainty).
1 finding from 1 review
Adverse events · patients with acute pancreatitis
It is very uncertain whether immunonutrition changes adverse events compared with control (very low certainty).
1 finding from 1 review
All‐cause mortality · patients with acute pancreatitis
1 finding from 1 review
Systemic inflammatory response syndrome ‐ not reported · patients with acute pancreatitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Organ failure ‐ not reported · patients with acute pancreatitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not reported · patients with acute pancreatitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found